Squamous cell carcinoma of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the present study, a novel lncRNA, SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1) was exhibited in ESCC.
|
29552140 |
2018 |
Neuropathy
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Consequently, SBF2 mutation analysis should not be restricted to individuals with coincident neuropathy and glaucoma, and CMT4B2 patients without glaucoma should be followed for increased intraocular pressure.
|
30028002 |
2018 |
Intraocular pressure disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Consequently, SBF2 mutation analysis should not be restricted to individuals with coincident neuropathy and glaucoma, and CMT4B2 patients without glaucoma should be followed for increased intraocular pressure.
|
30028002 |
2018 |
Sensorimotor neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Biallelic SBF2 mutations cause Charcot-Marie-Tooth disease type 4B2 (CMT4B2), a sensorimotor neuropathy with autosomal recessive inheritance and association with glaucoma.
|
30028002 |
2018 |
SVEINSSON CHORIORETINAL ATROPHY
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Rare variants in SBF2, a CMT gene, predict an increased risk of TIPN in AA patients receiving paclitaxel.
|
27732968 |
2016 |
Charcot-Marie-Tooth Disease, Type Ib
|
0.010 |
Biomarker
|
disease |
BEFREE |
Whereas myelin outfoldings are a pathological hallmark of autosomal recessive CMT4B1 and CMT4B2, due to mutations in myotubularin-related 2 (MTMR2) and 13 (MTMR13) genes respectively, they may also occur in nerve biopsies from CMT1B patients.
|
25388615 |
2015 |
Neuromuscular Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.
|
25462154 |
2014 |
Adenocarcinoma of pancreas
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Germline genetic variation in the SBF2 locus was associated with overall survival in patients with pancreatic adenocarcinoma of European and Asian ancestry.
|
23180869 |
2014 |
Thrombocytopenia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The fact that this mutation is found in SBF2 gene may indicate that the underlying cause of thrombocytopenia in our patient is either a new variant form of Griscelli syndrome (through the Rab GTPases action) or a variant Charcot-Marie-Tooth type 4 disease as SBF2 truncating mutations were previously identified in sufferers of this disease.
|
23334996 |
2013 |
Hypopigmentation-immunodeficiency disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The fact that this mutation is found in SBF2 gene may indicate that the underlying cause of thrombocytopenia in our patient is either a new variant form of Griscelli syndrome (through the Rab GTPases action) or a variant Charcot-Marie-Tooth type 4 disease as SBF2 truncating mutations were previously identified in sufferers of this disease.
|
23334996 |
2013 |
Inherited neuropathies
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in myotubularin-related protein-2 (MTMR2) or MTMR13/set-binding factor-2 (SBF2) genes are responsible for the severe autosomal recessive hereditary neuropathies, Charcot-Marie-Tooth disease (CMT) types 4B1 and 4B2, both characterized by reduced nerve conduction velocities, focally folded myelin sheaths and demyelination.
|
16399794 |
2006 |
Early-Onset Glaucoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.
|
12687498 |
2003 |
Peripheral demyelinating neuropathy
|
0.020 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth type 4B2 demyelinating neuropathy in miniature Schnauzer dogs caused by a novel splicing <i>SBF2 (MTMR13)</i> genetic variant: a new spontaneous clinical model.
|
31772832 |
2019 |
Peripheral Neuropathy
|
0.020 |
Biomarker
|
group |
BEFREE |
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
|
27732968 |
2016 |
Charcot-Marie-Tooth disease, Type 4B1
|
0.020 |
Biomarker
|
disease |
BEFREE |
The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.
|
23297362 |
2013 |
Charcot-Marie-Tooth disease, Type 4B1
|
0.020 |
Biomarker
|
disease |
BEFREE |
Given the genetic association of both MTMR2 and MTMR13 with CMT4B, we investigated the biochemical relationship between these two proteins.
|
15998640 |
2005 |
Peripheral demyelinating neuropathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The consistent phenotypic features associated with SBF2 mutations are early-onset demyelinating neuropathy, myelin folding, and markedly decreased motor nerve conduction velocities; glaucoma associates with SBF2 nonsense mutations.
|
15304601 |
2004 |
Peripheral Neuropathy
|
0.020 |
GeneticVariation
|
group |
BEFREE |
It is striking to note that mutations in MTMR13 also cause peripheral neuropathy with myelin outfoldings, although it belongs to a pseudophosphatase subgroup, since its closest homologue is MTMR5/Sbf1.
|
12687498 |
2003 |
Peripheral Nervous System Diseases
|
0.030 |
Biomarker
|
group |
BEFREE |
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
|
27732968 |
2016 |
Peripheral Nervous System Diseases
|
0.030 |
Biomarker
|
group |
BEFREE |
The PtdIns3P and PtdIns(3,5)P(2) 3-phosphatase myotubularin gene is mutated in X-linked centronuclear myopathy, whereas its homologs MTMR2 and MTMR13 and the PtdIns(3,5)P(2) 5-phosphatase SAC3/FIG4 are implicated in Charcot-Marie-Tooth peripheral neuropathies.
|
18429927 |
2008 |
Peripheral Nervous System Diseases
|
0.030 |
GeneticVariation
|
group |
BEFREE |
It is striking to note that mutations in MTMR13 also cause peripheral neuropathy with myelin outfoldings, although it belongs to a pseudophosphatase subgroup, since its closest homologue is MTMR5/Sbf1.
|
12687498 |
2003 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Malignant tumor of colon
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
|
31089142 |
2019 |
Colorectal Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
|
31089142 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |